Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2007 Posters: Improvement of Long-Term Results After Preoperative Chemoradiation for Rectal Carcinoma: Myth Or Reality?
2007 Program and Abstracts | 2007 Posters
Improvement of Long-Term Results After Preoperative Chemoradiation for Rectal Carcinoma: Myth Or Reality?
Arsen Rasulov*, Pavel Eropkin, Elena Simakina, Elena Markova
State Scientific Center of Coloproctology, Moscow, Russian Federation

Aim: To determine influence of preoperative chemoradiation (CRT) for rectal cancer (RC) on long-term results.
Patients and Methods: 169 patients with locally advanced RC were included into prospective trial. Of them 83 received CRT [T3(89.7%) and T4(10.3%)] and 86 had surgery alone [T3(88.2%) and T4(11.8%)]. CRT was delivered as external beam irradiation in 2 sessions per day 5 days a week up to total dose of 4500cGy with chemotherapy of 5FU 225mg/m2 daily given as bolus IV before RT. Surgery was performed 4-6 weeks later.
Results: CRT resulted in downsizing of 73 (87.9%) RC and downstaging in 54.4%. Damage of tumor cells detected in 65.6% of specimens. Downstaging of tumor after CRT for T stage was seen in 32, for N stage - in 2, and for both - in 3 patients. There was 3 fold decrease in T4 (from 10.3% to 2.9%) and 2 fold in T3 (from 89.7% to 50%). Following downstaging has been found: T2 - 25%, T1- 2.9%, Tx (focal adenocarcinoma) - 2.9%. Complete pathologic response was found in 9 specimens (T0N0 - 13.2%) and T0N1 in 2(2.9%). Curative resection with TME was done in 68 (81,9%) of CRT group and 77 (89.5%) in control group. It is of importance, that CRT allows to perform sphincter-saving procedures for 16.2% patients with low rectal carcinomas located within 4-5cm from anal verge initially regarded as candidates for APR.Local recurrences rate (LRR) was 8.6% in radiosensitive RC and 14.3% in radioresistant RC (p=0.47), distant metastases were occurred in 8.6% and 19.3% accordingly (p=0.13). There was increase in 5-year disease-free survival (DFS) of patients with radiosensitive RC 68.6% comparing to radioresistant RC 39.3% (p=0.015). In accordance to T-stage DFS was 100% for complete pathologic response; 100% for T1; 68.7% for T2; 40% for T3. Both patients with T0N1 died because of distant recurrence. DFS was significantly better for pT0-1 -75.8% vs. pT3 - 40% (p=0.02) and for pN0 - 73.3% vs. pN1 25.0% (p=0.017). The majority (90%) of died patients, who undergone CRT had T2-T3. Only 2 patients had T0N1 and in 1 case - TxN0.Despite no difference in DFS between CRT 55.6% and surgery alone 45.8%, (p=0.26), the trend towards better local control in radiosensitive RC (LRR 8.6%) comparing to surgery alone (LRR 21.4%) was found. Also significantly better survival was achieved in radiosensitive RC vs. surgery alone: 68.6% and 45.76%, correspondingly (p=0.04).
Conclusion: CRT significantly improves 5-year survival in patients with radiosensitive RC. Further investigations aimed at determination of radio- and chemosensitivity criteria for RC are mandatory. In our opinion it will allow better selection of patients for preop-CRT.


2007 Program and Abstracts | 2007 Posters


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards